Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population
- 5 October 2023
- journal article
- letter
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 59 (12) , 842-845
Abstract
No abstract availableFunding Information
- SEPAR
- AstraZeneca España
This publication has 8 references indexed in Scilit:
- Prevalence of Patients with Uncontrolled Asthma Despite NVL/GINA Step 4/5 Treatment in GermanyJournal of Asthma and Allergy, 2022
- Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with BenralizumabAdvances in Therapy, 2022
- Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Reslizumab: Spanish Real-Life DataJournal of Asthma and Allergy, 2022
- An expert consensus framework for asthma remission as a treatment goalJournal of Allergy and Clinical Immunology, 2020
- Targeting treatable traits in severe asthma: a randomised controlled trialEuropean Respiratory Journal, 2019
- Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS studyRespiratory Medicine, 2019
- After asthma: redefining airways diseasesThe Lancet, 2018
- Measurement of asthma control according to global initiative for asthma guidelines: a comparison with the asthma control questionnaireRespiratory Research, 2012